Rho GTPases, including the Rho, Cdc42, Rac, and ROP subfamilies, act as pivotal signaling switches in various growth and developmental processes. Compared with the well-defined role of cytoskeletal organization in Rho signaling, much less is known regarding transcriptional regulation. In a mutant screen for phenotypic enhancers of transgenic Arabidopsis plants expressing a constitutively active form of ROP2 (designated CA1-1), we identified RNA polymerase II (Pol II) C-terminal domain (CTD) phosphatase-like 1 (CPL1) as a transcriptional regulator of ROP2 signaling. We show that ROP2 activation inhibits CPL1 activity by promoting its degradation, leading to an increase in CTD Ser5 and Ser2 phosphorylation. We also observed similar modulation of CTD phosphorylation by yeast Cdc42 GTPase and enhanced degradation of the yeast CTD phosphatase Fcp1 by activated ROP2 signaling. Taken together, our results suggest that modulation of the Pol II CTD code by Rho GTPase signaling represents an evolutionarily conserved mechanism in both unicellular and multicellular eukaryotes.
Rho GTPases, including the Rho, Cdc42, Rac, and ROP subfamilies, act as pivotal signaling switches in various growth and developmental processes. Compared with the well-defined role of cytoskeletal organization in Rho signaling, much less is known regarding transcriptional regulation. In a mutant screen for phenotypic enhancers of transgenic Arabidopsis plants expressing a constitutively active form of ROP2 (designated CA1-1), we identified RNA polymerase II (Pol II) C-terminal domain (CTD) phosphatase-like 1 (CPL1) as a transcriptional regulator of ROP2 signaling. We show that ROP2 activation inhibits CPL1 activity by promoting its degradation, leading to an increase in CTD Ser5 and Ser2 phosphorylation. We also observed similar modulation of CTD phosphorylation by yeast Cdc42 GTPase and enhanced degradation of the yeast CTD phosphatase Fcp1 by activated ROP2 signaling. Taken together, our results suggest that modulation of the Pol II CTD code by Rho GTPase signaling represents an evolutionarily conserved mechanism in both unicellular and multicellular eukaryotes.
Rho GTPase | ROP GTPase | Pol II | CTD code | CPL1 R ho family GTPases, including four subfamilies, Rho, Cdc42, and Rac in yeast and animals and ROP in plants, are key plasma membrane-associated signaling switches (1) (2) (3) . Genetic evidence has shown that these Rho GTPases are involved in a wide range of growth and developmental processes, including cell migration, division, differentiation, tissue morphogenesis, and organ development. In Arabidopsis, there are 11 members of ROP, each with unique and sometimes overlapping functions in cell morphogenesis, cell growth, and response to hormones and various biotic and abiotic stresses (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Recent studies have shown that three closely related members, ROP2, ROP4, and ROP6, function in cell polarity control through microtubule and actin cytoskeletal organization (3, 8, 10, 12, 13) , but involvement of transcriptional regulation remains unknown.
RNA polymerase II (Pol II) is a multiunit holoenzyme complex critical for transcription in eukaryotic organisms. Its largest subunit, RPB1, has a C-terminal domain (CTD) that contains various numbers of the heptad peptide (Y 1 S 2 P 3 T 4 S 5 P 6 S 7 ) repeats (14) (15) (16) (17) . These repeats undergo dynamic posttranslational modifications, such as phosphorylation of Tyr1, Ser2, Thr4, Ser5, and Ser7. Because of their combinatorial complexity and importance in regulating gene expression, these modifications are collectively termed the "CTD code" (14) (15) (16) (17) . Dynamic modulation of the CTD code in Pol II along genes is essential for completing various key steps of transcriptional process by recruiting the CTDassociated proteins to the transcribing Pol II. A number of protein kinases and phosphatases have been shown to regulate the CTD Ser phosphorylation dynamics in yeast, plant, and animal cells (14) (15) (16) (17) . In Arabidopsis, there are several members of CTD phosphatases with sequence homology to yeast Fcp1 phosphatase (18) (19) (20) (21) . Among these members, CPL1 has been extensively studied in stress response and gene expression regulation (18, 19, (22) (23) (24) (25) . CPL1 has been demonstrated to act as a Ser5 phosphatase in vitro, but its upstream regulatory pathway remains to be revealed.
Our work presented here establishes an unexpected link between Rho signaling and the Pol II CTD code modulation via CTD phosphatase in both Arabidopsis and yeast systems. Using a forward genetic screen, we identified the CPL1 (CTD phosphatase-like 1) gene as a transcriptional regulator of ROP2 signaling in the control of cell shape, cell size, and cell number. We have shown that activation of ROP2 signaling stimulates the CTD Ser5 and Ser2 phosphorylation status by inhibiting CPL1. In addition, we found that auxin, which is known to activate ROP2 Significance Rho GTPase and polymerase II (Pol II), two key molecules involved in cellular signaling and transcription in eukaryotic organisms, have been separately studied for more than 2 decades without evidence showing their functional linkage. We provide genetic and biochemical evidence linking these two molecules in an intracellular signaling pathway. Rho GTPases in Arabidopsis and yeast can modulate the phosphorylation status of the Pol II C-terminal domain (CTD) by inhibiting the CTD phosphatases. Our finding renders strong support for a direct or "shortcut" model in transcriptional control. Compared with the classical transcriptional activator/ repressor-mediated indirect model, this shortcut model of targeting the core of Pol II likely provides an efficient transcriptional control to rapidly bring about the broad changes in gene expression.
signaling (10) , increased CTD Ser5 and Ser2 phosphorylation in a ROP2-dependent manner. Moreover, we observed similar modulation of the CTD code by Cdc42 GTPase activity in fission yeast and similar protein degradation of a CPL1 homolog in the budding yeast. Therefore, our results demonstrate that modulation of the Pol II CTD code by Rho GTPases via inhibiting CTD phosphatases represents an evolutionarily conserved mechanism in both unicellular and multicellular eukaryotes.
Results
Isolation of an Arabidopsis cae2/cpl1 Mutant That Enhanced the Phenotypes of Transgenic Plants Expressing CA-rop2. To identify regulators or effectors of ROP2 signaling, we mutagenized a transgenic line, designated CA1-1, which overexpresses a constitutively active form of ROP2 (CA-rop2 or ROP2 G15V ) (26) and isolated several recessive monogenic recessive ca-rop2 enhancers (cae). Among these, cae1 has a mutation in the kinesin gene and enhances the root hair phenotypes of CA1-1 (27) , and cae2-1 is characterized here. As observed by others (13, 28) , the cotyledon pavement cells in CA1-1 had a fat, hyperparallel, near-rectangular shape (Fig. 1A) , compared with wild-type (WT), which exhibited a typical interdigitating puzzle-like cell shape. Although cae2-1 itself did not alter the cell shape, cae2-1 in the CA1-1 background (cae2-1 CA1-1) had cotyledon pavement cells that were regularly spaced and near-square shaped and lacked obvious lobes (Fig. 1A) . Quantitative analysis using the Shape Factor (29) , which has a value twofold higher than Circularity used in another study (11) , showed that CA1-1 had a higher Shape Factor (0.55) than WT and cae2-1 (0.22), but cae2-1 CA1-1 had a cell Shape Factor of 0.76 (Fig. 1B) , confirming that cae2-1 CA1-1 is a CA1-1 enhancer. To determine whether other cell parameters were also affected by the enhancer mutation during cotyledon growth, we analyzed cell images collected from 3-to 6-d-old cotyledons (SI Appendix, Fig. S1A ) using a different cell-clearing method (30) . We found that CA1-1 cells at day 6 also had a slightly smaller area on average than WT and that cae2-1 CA1-1 had the smallest cells at all stages (SI Appendix, Fig. S1B ). In contrast, whereas Shape Factors in WT and cae2-1 similarly decreased during cotyledon growth, CA1-1 kept larger Shape Factors and cae2-1 CA1-1 had the largest ones at all stages. Consistently, the cae2-1 CA1-1 cotyledon had more cells than all three other genotypes. Therefore, cae2-1 greatly enhanced CA1-1 in terms of cell shape, size, and number.
Through map-based cloning, we identified a G-to-A mutation in the first nucleotide of the 11th intron of At4g21670 (Fig. 1C) . This gene was first identified as CPL1 or FRY2, which encodes a Pol II CTD phosphatase involved in stress responses and acting as a regulator of gene expression (18, 19, (22) (23) (24) (25) . The cae2-1 mutation resulted in three types of splicing products of CPL1 mRNA in cae2-1 CA1-1, and sequencing of the three cDNA molecules showed all of which differed from the WT CPL1 transcript ( Fig. 1D ; SI Appendix, Fig. S2 A and B) . The enhanced cell-shape phenotype of cae2-1 CA1-1 was complemented in transgenic plants with a 7.7-kb CPL1 genomic fragment (SI Appendix, Fig. S2C ). In addition, crossing CA1-1 into fry2-1 phenocopied the pavement cell shape of cae2-1 CA1-1 (SI Appendix, Fig. S2D ), demonstrating that the CPL1 mutation is responsible for the enhancer phenotype and thus that CAE2 is allelic to CPL1. As CPL1 is involved in transcriptional control, we investigated whether cae2-1 impacted ROP2 expression. We found that all four genotypes exhibited a similar expression level of WT ROP2, although the expression level of the CA-rop2 transgene in cae2-1 CA1-1 was twofold of that in CA1-1 (SI Appendix, Fig. S3A ). In addition, despite a role for CPL1 in regulating expression of osmotic stress-responsive genes (19) , we found that the enhancer phenotype of cae2-1 CA1-1 is not caused by osmotic stress (SI Appendix, Fig. S4 ).
Alteration of Ser5 and Ser2 but Not Ser7 Phosphorylation Status of Pol II CTD in CPL1 Mutants. CPL1 has been demonstrated to act as a specific protein phosphatase dephosphorylating the CTD Ser5 residue of RPB1 in vitro (31) . To confirm that CPL1 acts in vivo, we examined the CTD Ser5 phosphorylation (Ser5P) status in cae2-1. Results showed that Ser5P was up-regulated in cae2-1 by 1.8-fold compared with WT without affecting the total RPB1 protein level ( Fig. 1 E and F) . Surprisingly, Ser2 phosphorylation (Ser2P) was also up-regulated (1.4-fold) in cae2-1, whereas Ser7P was not affected. Consistently, Ser5P and Ser2P levels were also higher in cae2-1 CA1-1 than in CA1-1 ( Fig. 1 E and F) . Such differential Ser phosphorylation pattern was also observed in fry2-1 ( Fig. 1 G and H) . Our result shows the function of CPL1 as a CTD Ser5 phosphatase in vivo and reports an unexpected consequence of CPL1 mutations in Ser2 dephosphorylation. Interestingly, comparison of the Ser5P and Ser2P levels between WT and CA1-1 indicated that CA1-1 had higher levels of Ser5P (3-fold) and Ser2P (1.8-fold) than WT, whereas Ser7P and RPB1 total protein levels were not affected ( Fig. 1 E and  F) . This difference was also observed by comparing cae2-1 and cae2-1 CA1-1. This indicates that the phosphorylation status of Ser5 and Ser2 but not Ser7 is modulated by ROP2 signaling. To confirm this finding, we examined Ser5P and Ser2P in the ROP2 loss-of-function mutant. As ROP2 and ROP4 act redundantly in the formation of pavement cell shape (13), we used ROP2
RNAi rop4-1, a ROP2 RNA interference (RNAi) transgenic line in the rop4-1 knockout mutant background, which greatly suppressed ROP2 expression (13) . We found that both Ser5P and Ser2P levels decreased dramatically in ROP2 RNAi rop4-1, without affecting Ser7P and total RPB1 protein ( Fig. 1 I and J) . Therefore, these genetic data consistently showed that activation of ROP2/4 GTPases leads to modulation of the Pol II CTD phosphorylation at the Ser5 and Ser2 positions rather than global CTD phosphorylation.
Next, we tested whether a signal that activates ROP2/4 activity also altered the CTD phosphorylation status. Auxin has been demonstrated to activate Arabidopsis ROP2/4 GTPases (10) and tobacco ROP/Rac1 GTPases (5). In Arabidopsis, alteration of the cotyledon cell shape by auxin treatment is mediated by ROP2/4 (10), and thus we investigated whether Ser5 and Ser2 phosphorylation could be impacted by the exogenous auxin treatment. We found that levels of Ser5P and Ser2P, but not Ser7P, slightly increased in 1 μM naphthaleneacetic acid-treated WT compared with the control, but ROP2 RNAi rop4-1 did not exhibit such activation (SI Appendix, Fig. S5 ). This result shows that elevation of Ser5P and Ser2P by auxin is dependent upon functional ROP2/4 GTPases, consistent with our finding that ROP2/4 signaling modulates the specific Pol II CTD code.
CPL1 and CPL2 Have a Similar Function in CTD Phosphorylation and
Act Redundantly in Cell Growth and Morphogenesis. Interestingly, comparison of the CTD phosphorylation status in CA1-1 and cae2-1 showed that cae2-1 has slightly lower Ser5P and Ser2P levels than CA1-1 ( Fig. 1 E and F) . This might explain why cae2-1 has not exhibited cellular phenotypes observed in CA1-1. As fry2-1 has not shown any cotyledon pavement cell phenotype either, it is possible that CPL2, another CTD phosphatase homologous to CPL1, has a redundant function with CPL1 and that activation of ROP2 signaling suppresses both CPL1 and its close homolog. Earlier studies reported that CPL2, a close homolog of CPL1, plays a partially redundant role with CPL1, and that their double mutant is lethal (22, 31) . To test the functional redundancy possibility, we characterize CPL2. Consistent with the earlier reports, we found that, like cae2-1, cpl2-2 was also able to enhance the CA1-1 cell-shape phenotype after it was crossed into CA1-1 (SI Appendix, Fig. S6A ). Thus, the further increase of Ser5P levels in cae2-1 CA1-1 compared with CA1-1 ( Fig. 1 E and F) could also be caused by the possibility that activation of ROP2 signaling suppresses both CPL1 and CPL2. We then constructed a homozygous double-mutant cae2-1 cpl2-2 and found that it exhibited severe growth inhibition and fertility reduction (SI Appendix, Fig. S6B ). When the double mutant and cae2-1, which did not affect fertility, were crossed, only two or three seeds were obtained in each silique using cae2-1 cpl2-2 as female and no seeds were obtained from the reciprocal cross, indicating that male fertility was more severely compromised than female. However, at the end of the life cycle, a few seeds derived from self-fertilization of each cae2-1 cpl2-2 plant were recovered and subsequently used for biochemical analysis and cell-shape RT-PCR analysis of CAE2/CPL1 expression in WT, CA1-1, and cae2-1 CA1-1. There was no difference in CPL1 expression level between WT and CA1-1, but three splicing products (CAE2-A, CAE2-B, and CAE2-C) were PCR-amplified using primer pairs CZP17 and CZP18 in cae2-1 CA1-1. ACT2 (Actin2) was used as an internal control. (E and F) Alteration of Ser5P and Ser2P in WT, CA1-1, cae2-1, and cae2-1 CA1-1 (E) and the quantitative analysis (F). The proteins were analyzed by Western blot using Ser5P-, Ser2P-, and Ser7P-specific and anti-CTD antibodies. Tubulin was used as the protein-loading control detected with an anti-tubulin antibody. WT, wild type. (G and H) Alteration of Ser5P and Ser2P in fry2-1 (G) and the quantitative analysis (H). (I and J) Reduced Ser5P and Ser2P in ROP2 RNAi rop4-1 (I) and the quantitative analysis (J). Values in F, H, and J are means ± SD (n = 3 biological replicates) with different letters within the same category indicating a statistical difference (P < 0.05; pair-wise t test).
characterization. We found that, similar to cae2-1, cpl2-2 also had higher Ser5P and Ser2P levels than WT without affecting Ser7P and total RPB1 levels and that cae2-1 cpl2-2 had the highest levels of Ser5P and Ser2P (Fig. 2 A and B) . Similar to cae2-1, cotyledon pavement cell shape, cell size, and cell number in cpl2-2 were indistinguishable from WT, but cae2-1 cpl2-2 exhibited a phenotype in all three growth and geometric parameters ( Fig. 2 C and D; SI Appendix, Fig. S7 ). Taken together, our results suggest that CPL1 and CPL2 are similarly involved in CTD Ser5 and Ser2 dephosphorylation and likely act redundantly in cotyledon pavement cell growth and morphogenesis.
ROP2 Signaling Inhibits CPL1 Activity by Promoting CPL1 Degradation.
To investigate how ROP2 signaling regulates CPL1 function in the control of CTD Ser5 and Ser2P phosphorylation, we first tested whether CPL1 overexpression could suppress the elevated Ser5P and Ser2P levels and cell-shape defect in CA-rop2 transgenic plants.
To minimize transgene silencing, we used different promoters to drive the expression of CA-rop2 (UBQ10 promoter; designated UBCA1) and CPL1 (CaMV 35S; designated 35S:CPL1). Indeed, we did not observe any impact in CA-rop2 transgene expression in transgenic plants overexpressing CPL1 (SI Appendix, Fig. S3B ). Interestingly, we found that 35S:CPL1 in UBCA1 decreased Ser5P and Ser2P to a level close to that in WT without affecting Ser7P and total RPB1 levels ( Fig. 3 A and B) , consistent with our findings that both Ser5P and Ser2P levels were higher in the cpl1 mutants (Fig. 1  E-H; Fig. 2 A and B) . Furthermore, overexpression of CPL1 in UBCA1 strongly, although not fully, restored the interdigitating cell-shape defect caused by CA-rop2 overexpression (Fig. 3C) . These results support the notion that CPL1 may act downstream of ROP2 signaling.
We then tested whether ROP2 signaling inhibits CPL1 transcription or protein stability. Gene expression analysis revealed that CA1-1 and WT had a similar CPL1 mRNA level ( Fig. 1D ; SI Appendix, Fig. S8A ). To determine whether ROP2 signaling affects CPL1 protein stability, we generated transgenic lines expressing Flagand Strep II-tagged CPL1 (designated CPL1-FAST). Expression of 35S:CPL1-FAST strongly suppressed the UBCA1 cell-shape phenotype (SI Appendix, Fig. S8B ), like 35S:CPL1 (Fig. 3C) , indicating that the FAST tags did not interfere with the CPL1 function. Using an in vitro protein degradation assay, we found that CPL1-FAST was more rapidly degraded in CA1-1 extracts at 45 min than that in WT (Fig. 3 D and E) . At 90 min, whereas WT extracts showed a substantial degradation of CPL1-FAST, it was almost completely degraded in CA1-1. However, addition of protein degradation inhibitors MG132 and lactacystin for 1.5 h reduced the CPL1-FAST degradation, indicating a potential involvement of the proteasome-mediated degradation mechanism. Taken together, our genetic and biochemical evidence suggests that ROP2 GTPase signaling suppresses CPL1 activity by promoting its degradation.
Alteration of ROP2 and CPL1 Activities Impacts Expression of a Common
Subset of Genes. Given the role of CTD Ser5 phosphorylation in the Pol II control of gene expression (18, 19, (22) (23) (24) , we performed transcriptome analysis to determine whether ROP2 and CPL1 affected expression of a similar set of downstream genes. RNAsequencing analysis revealed that 1,333 genes were differentially expressed (with a twofold cutoff) in cae2-1, CA1-1, or cae2-1 CA1-1 compared with WT (SI Appendix, Fig. S9A ). Approximately 43% of those differentially expressed genes in CA1-1 were also affected in cae2-1 (SI Appendix, Fig. S9A ), suggesting that a sizable common subset of genes was similarly controlled by CPL1 and ROP2. Furthermore, expression of a subset of CA1-1-affected genes was further enhanced by the CPL1 mutation in cae2-1 CA1-1 (SI Appendix, Fig. S9B ). In addition, 49 genes, the products of which are predicted to localize to the cell wall or be involved in cell-wall modification, were also differentially expressed in these genotypes (SI Appendix, Fig. S9C ). The cell wall has been recognized to play a critical role in cell-shape formation or ROP signaling (11, 32, 33) . Consistently, we found that some of the cell-wall-related genes that were up-regulated in CA1-1 and/or cae2-1 were further enhanced in cae2-1 CA1-1, including those encoding pectin methylesterase 17 (PME17), wall-associated kinase 1 (WAK1), and a putative invertase (At2g47550) (SI Appendix, Fig. S9C ). The expression pattern of these three genes revealed by RNA sequencing was validated using quantitative RT-PCR analysis (SI Appendix, Fig. S9D ). Importantly, up-regulation of these genes by activated ROP2 was inhibited in the 35S:CPL1 transgenic line (SI Appendix, Fig. S9E ). Together, these results support that ROP2 signaling modulates the CTD code in transcriptional control by inhibiting CPL1.
Activation of Pol II CTD Phosphorylation by Rho GTPase Is Conserved in Yeast. The finding in Arabidopsis that ROP2 signaling modulates the CTD phosphorylation led us to examine whether modulation of the CTD code by Rho GTPases is evolutionarily conserved. This was motivated by early observations that Ras GTPase signaling was implicated in modulating Pol II in yeast (34) and rat cell culture (35) . In budding yeast (Saccharomyces cerevisiae), the Ras-PKA signaling pathway does not directly target Rpb1 CTD; instead, PKA directly phosphorylates Srb9, a component of Pol II holoenzyme (34) . To test the hypothesis that yeast may use Rho rather than Ras to modulate CTD phosphorylation, we first used the fission yeast Schizosaccharomyces pombe, which shows a clear cell-shape change by activation of Rho GTPases such as Rho4 and Cdc42 (36) (37) (38) . We expressed Arabidopsis CA-rop2 with the thiamine-repressible nmt1 promoter in yeast cells. In the presence of thiamine, the CA-rop2 transformants did not alter the normal rod shape, but after 48 h of removing thiamine the CA-rop2 transformants had acquired the bulbous shape that was not observed in the vector control (Fig. 4A) . This indicates that constitutive activation of Arabidopsis ROP2 disrupted polarized growth in yeast, as with similar yeast Rho1 and Cdc42 gain-offunction mutants (36, 39) . CA-rop2 induction increased both Ser5P and Ser2P levels without altering the yeast Rpb1 level (Fig. 4 B and C) . Furthermore, we found a dramatic increase in Ser2P and Ser5P levels after only 1 h of CA-rop2 induction, at which time no morphological change in yeast cells could be observed (SI Appendix, Fig. S10 A-C) . This suggests that the stimulation of CTD phosphorylation by ROP2 signaling is more likely a direct effect rather than an indirect consequence of morphological changes. To substantiate that Rho-GTPase-signaling-mediated CTD phosphorylation is conserved in fission yeast, we used cdc42-1625, a loss-of-function Cdc42 mutant (40) that exhibited abnormal cell shapes (Fig. 4D ). cdc42-1625 had greatly reduced Ser5p and Ser2P levels (Fig. 4 E and F) , supporting that yeast Rho signaling also modulates CTD phosphorylation in the control of cell morphogenesis.
We then investigated whether plants and yeast use a conserved biochemical mechanism in modulating the CTD code by inhibiting CTD phosphatase. Because the antibody for Saccharomyces cerevisiae Fcp1, which acts as a Ser2 phosphatase (41) and is homologous to CPL1 and likely a CPL3 ortholog (21) , is available, budding yeast was analyzed. The Fcp1 protein level was lower in yeast transformants expressing CA-rop2 than in the vector control after 12 h of induction by galactose, and at the same time, the Ser2P level increased (SI Appendix, Fig. S10 D and E) . To better detect Fcp1, a budding yeast strain with the 3xFlag tags inserted in-frame into the C terminus of Fcp1 was used. We found that when protein degradation inhibitors MG132 and lactacystin were used, the Fcp1-3xFlag protein level in the CA-rop2-transformed strain was recovered, and concomitantly the Ser2P level decreased (Fig. 4 G and H) . Ser5P was similarly affected, consistent with an earlier finding that the fcp1 mutant also impacted Ser5 phosphorylation (42) . These results strongly suggest that a similar CTD phosphatase degradation mechanism operates in both Arabidopsis and yeast systems to regulate the Rho-GTPase-signaling-mediated modulation of Pol II CTD phosphorylation.
Furthermore, we investigated whether induction of CA-rop2 in fission yeast also mis-regulated expression of genes known to function in cell-shape formation. We found that CA-rop2 induction in yeast up-regulates (threefold) Rho1 and down-regulates (eightfold) Rga1 gene expression (SI Appendix, Fig. S10F ). Rga1 encodes a GTPase-activating protein that negatively regulates Rho1 activity, and rga1 null cells showed a swollen, multiseptated or branched shape (43), a phenotype similar to the cell expressing a constitutively active form of Rho1 (39) . The Cdc42-Rac-Rhosignaling cascade has been reported (44) , and our result indicates that ROP2 activation in fission yeast may up-regulate Rho1 at the transcriptional level. In addition, we found that expression of Pmc5 was 10-fold lower in CA-rop2 transformants (SI Appendix, Fig. S10F ). Given that Pmc5 is a transcriptional regulator, also called Med6 (mediator 6), and that pmc5 null cells are temperaturesensitive stubby, curved, septated, and misshapen (45) , suppression of Pmc5 expression by CA-rop2 induction indicates that Pmc5 may be another transcriptional target regulated by activation of ROP2 in fission yeast. These gene expression analyses indicate that Rho GTPase signaling alters transcription of yeast cell-shaperelated genes.
Finally, we tested whether Pol II Rpb1 CTD phosphorylation is important for the fission yeast cell-shape change induced by CA-rop2. Fission yeast has four imperfect heptad repeats followed by 25 consensus heptad repeats, and studies have shown that retaining the four imperfect repeats plus four consensus repeats will lead to lethality (46, 47) . Therefore, several studies toward understanding the CTD code in fission yeast have relied on changing the amino acid residues in 12-14 consensus repeats (47) (48) (49) . We obtained the strains carrying S2A (all Ser2 in 14 repeats changed to Ala), (S5) 3 (S5A) 11 (Ser5 in 11 repeats is changed to Ala while it remains the same in 3 other repeats), and (S5) 2 (S5A) 12 (Ser5 in only 12 repeats is changed to Ala) mutations and their WT (48, 49) for transformation with the nmt1 promoter driven CA-rop2. These mutants had a very similar shape to their WT when CA-rop2 was not induced in the presence of VB1 (Fig. 5) . Similar to an earlier observation (Fig. 5A) , the CA-rop2 induction caused the WT cells to develop into the oval or round shapes; however, S2A mutants partially suppressed the CA-rop2 effect, with many cells retaining the rod shape although being slightly shorter than the uninduced S2A cells. Although (S5) 3 (S5A) 11 mutant cells were similar to S2A, (S5) 2 (S5A) 12 mutants showed almost complete suppression except the occurrence of slightly swollen cells compared with the uninduced control (Fig. 5) . It is unlikely that the suppression of the CA-rop2 cell-shape phenotype was caused by inhibition of CA-rop2 expression because these S2A and S5A mutants had similar CA-rop2 protein levels as WT when induced in the absence of thiamine (SI Appendix, Fig.  S10G ). Therefore, this genetic interaction result suggests that CTD S2P and S5P are important targets for constitutively activated ROP2 signaling in cell-shape formation, with S5P playing a predominant role. Taken together, our genetic, biochemical, and gene expression evidence shows that Rho GTPase signaling in yeast targets the Pol II CTD code using an evolutionarily conserved CTD phosphatase degradation mechanism.
Discussion
Rho GTPase signaling and the Pol II CTD code modulation have been separately studied in yeast, plants, and animals for more than 2 decades. We present genetic and biochemical evidence in Arabidopsis to establish a surprising link between these two key molecules in intracellular signaling. In addition, we have found that Cdc42 GTPase signaling in yeast similarly modulates Pol II CTD Ser5 and Ser2 phosphorylation. Therefore, our results suggest that modulation of the Pol II CTD code by Rho GTPase signaling represents an evolutionarily conserved mechanism in intracellular signaling. This has led us to propose a model of the Rho GTPase modulation of the Pol II CTD code in eukaryotes (Fig. 6 ). In this model, a positive cue, such as auxin in plants, activates ROP2 signaling, leading to inhibition of CPL1, which in turn relieves its inhibition on CTD phosphorylation. Consequently, CTD becomes hyperphosphorylated at Ser5 and Ser2 sites. Such a CTD code modulation can quickly and strongly affect expression of those genes important for cell growth and shape formation. An important future direction is to understand how Rho GTPase signaling inhibits CPL1 function. One of the inhibitory mechanisms could be promotion of CPL1 protein degradation. Given that ROP has been shown to promote degradation of auxin-signaling-related proteins such as AUX in the nucleus (7), proteasome-based protein degradation could be another common mechanism in ROP signaling. Indeed, we have shown that activation of ROP2 signaling could lead to enhanced degradation of a CPL1 homolog in yeast (Fcp1) in vivo, indicating that yeast and plant cells likely employ a conserved biochemical mechanism to regulate the function of CTD phosphatases in Rho signaling. Future work toward understanding how Rho signaling mediates the proteasome-mediated CPL1 or Fcp1 degradation will fill in the gaps of this Rho GTPase-Pol II signaling pathway.
Our unexpected finding that links Rho GTPase signaling to the Pol II CTD code modulation has broad implications in the control of cell morphogenesis or cell growth in plants and other eukaryotes. In animals, regulation of Pol II by distinct signaling pathways (50) or its role in embryo development (51, 52) has been reported, but no Rho GTPase has been implicated in modulating Pol II activities. In plants, Rho signaling has been demonstrated to control cytoskeletal organization in cell morphogenesis, but no transcriptional regulator has been identified in plant cellshape formation. Thus, our finding that ROP2 signaling can also lead to Pol II CTD modulation is exciting. However, currently, we cannot distinguish whether cell shape, cell size, and number of phenotypes observed in CA1-1, cae2-1 CA1-1, and cae2-1 cpl2-2 are directly or indirectly caused by the changes in the Pol II CTD phosphorylation status. After controlling for the cell-size factor, cae2-1 CA1-1 still showed a statistically significant difference in Shape Factor compared with WT (SI Appendix, Fig. S1B ), indicating that the cell-shape phenotype of cae2-1 CA1-1 cannot be completely explained by the cell-size effect. Thus, although at present we cannot distinguish whether the pavement cell-shape alteration in cae2-1 CA1-1 is the cause or the consequence of cell number and/or size change due to the complex interactions between cell division, expansion, and morphogenesis (38, 53, 54) , it is possible that cae2-1 and CA1-1 impact both a common cell size and shape formation pathway and another pathway in the control of cell shape unrelated to cell size. In addition, it remains unknown whether CPL1 or Pol II also indirectly alters cytoskeleton organization or vesicle transport in the cotyledon cell growth and shape formation process. However, consistent with a critical role of Pol II in transcriptional control, we found a dramatic transcriptomic change in the cae2-1 CA1-1 enhancer mutant and the suppression of several cell-wall-related genes by CPL1 overexpression. This finding indicates a potentially important role for Pol II transcription in cell morphogenesis and growth. In corroboration with the importance of transcriptional control in ROP2-mediated cell morphogenesis, we found that expression of three cell-shape-related genes in fission yeast (Rho1, Rga1, and Pmc5) was altered by inducible expression of CA-rop2. Therefore, if an essential role for Rho-Pol II signaling pathway-exerted gene expression can be demonstrated in cell-shape determination, it will significantly expand the mechanistic understanding of cell growth and geometry determination beyond the well-studied cytoskeletal control.
It should also be noted that the Pol II CTD code modulation as measured by Western blots using Ser2P-and Ser5P-specific antibodies does not account for all of the cell geometric differences observed in CA1-1, cae2-1 CA1-1, and cae2-1 cpl2-2. For example, cae2-1 has slightly higher Ser5P and Ser2P levels than WT, but they are not sufficient to cause a cell-shape change; a larger increase in Ser5P and Ser2P in CA1-1 leads to a dramatic change in cell shape, and a further increase in Ser5P and Ser2P levels in cae2-1 CA1-1 causes the most dramatic cell-shape change ( Fig. 1 A and B; SI Appendix, Fig. S1 ). This strongly suggests that the highly phosphorylated CTD is the cause for the cell-shape change. However, cae2-1 cpl2-2 has even higher Ser5P and Ser2P levels than CA1-1, but the double mutant does not show a stronger cell-shape change than CA1-1. Although the double-mutant cae2-1 cpl2-2 has similar Ser5P and Ser2P levels and cell sizes as cae2-1 CA1-1, they still exhibited different cell shapes than the enhancer cae2-1 CA1-1. This discrepancy could be due to the fact that ROP2 and CPL1/2 impact on slightly different distributions of the phosphorylated Ser5 and/or Ser2 in various heptad peptide repeats within the CTD. In fission yeast, the combination of Ser2 and Ser5 phosphorylation status in the CTD code theoretically would lead to 4 n distinct primary structures, where n is the number of heptad repeats, and thus "reading" this large number of distinct and complex sets of the CTD code becomes critical in relaying upstream biological information to transcriptional control (48, 49) . Our finding that the (S5) 2 (S5A) 12 mutant almost completely suppressed the cell-shape phenotype caused by the CA-rop2 induction and the S2A and (S5) 3 (S5A) 11 mutants exhibited only partial suppression suggests that the number of the Ser5-phosphorylated heptad repeats in the CTD is critical for Rho-GTPase-mediated cell-shape control. Therefore, it is necessary to determine whether Rho signaling modulates distinct CTD codes in each heptad repeat dynamically in response to both external factors and internal cues. Alternatively or additionally, the discrepancy could be due to the possibility that ROP2 signaling also targets other factors. For example, CTD kinases (55) might be potential targets, as we have found that overexpression of CPL1 could not fully, although it could strongly, restore the cell-shape defect in UBCA1. Other CPL1 substrates or interacting proteins, such as HYL1 (22) and the nonsense-mediated decay factors eIF4AIII and UPF3 (56), might also be regulated by ROP2 signaling. Therefore, it is important to investigate all of these possibilities for a better understanding of how Rho GTPase regulates gene expression.
Our findings in yeast and plant systems on the modulation of the CTD code by Rho signaling render a strong support for an evolutionarily conserved "shortcut" model in the control of Pol II transcription for both unicellular and multicellular eukaryotes. Prior work in yeast showing the interaction of Snf1 kinase or Ras-PKA signaling with components of the Srb/Mediator complex has led to the proposal of a shortcut, "bypass," or direct model in transcriptional control (34, 57) . Compared with the classical transcriptional activator/repressor-mediated indirect model, this shortcut or direct model, by targeting the Pol II holoenzyme, has been argued to provide an efficient control of transcription to rapidly bring about the broad changes in gene expression (34, 57) . Our work suggests that eukaryotes likely share a transcriptional regulatory mechanism by which Rho signaling targets the Pol II CTD code itself. Nevertheless, the evidence that Rho signaling directly activates a nuclear proteasome pathway is needed to demonstrate the Rho-CTD shortcut model. There are at least two possibilities for such regulation. One is a Rho-signaling molecule that can directly phosphorylate CTD, such as PKA-mediated phosphorylation of the Srb/Mediator complex in yeast Ras signaling (34) , or that can translocate into the nucleus to activate the CPL1 or Fcp1 degradation. The other possibility is that Rho itself could be translocated into the nucleus and acts upon the proteasome to degrade CTD phosphatases. It should be noted that such nuclear localization or nucleocytoplasmic shuttling has been reported for Rac1 GTPase (58) . Clearly, one important future direction is to dissect the mechanism by which Rho signaling directly exerts its effect in nuclear degradation of CTD phosphatases or regulation of CTD kinases. If the proposed Rho-Pol II shortcut model of transcriptional control can be convincingly demonstrated, it will shed light on the complex, and yet efficient cellular regulatory systems such as this model will enable eukaryotes to rapidly respond to various internal and external cues during growth and development, thereby increasing the environmental fitness of eukaryotes. 
Materials and Methods
Experimental details are provided in SI Appendix, SI Materials and Methods.
Plant Materials and Growth. Arabidopsis thaliana Columbia WT and cpl2-2 (SALK_059753) were obtained from The Arabidopsis Information Resource. For cotyledon cell-shape and protein degradation analyses, soil-grown seedlings were used if not otherwise specified. For protein analysis, liquidcultured seedlings were used. For transgenic plants first described in this paper, homozygous plants of T3 or T4 generations were used in most phenotypic characterizations and biochemical or gene expression studies. At least four independent homozygous lines were used for initial Western blot and phenotypic studies, and one of these that showed similar results to other lines was chosen as a representative for presentation in all figures.
Map-Based Cloning and Complementation Test. cae2-1 CA1-1 was crossed to ecotype Landsberg erecta for mapping the CAE2 gene. To complement the cae2-1CA1-1 phenotype, a 7.7-kb CPL1 genomic fragment was transformed into cae2-1 CA1-1.
RNA-Sequencing Data Analysis. Total RNA was extracted from shoots of 7-dold seedlings of WT, CA1-1, cae2-1, and cae2-1 CA1-1, each genotype with two biological replicates. RNA sequencing was performed via Illumina HiSeqTM 2000 and raw data (deposited in the National Center for Biotechnology Information Gene Expression Omnibus database; accession no. GSE78118) were preprocessed by Beijing Genomics Institute Tech Solutions Co. Differentially expressed genes between two genotypes were identified using the exact test for negative binomial models implemented in EdgeR (59) . Statistically significant genes had at least twofold changes and a false discovery rate value less than 0.1.
Plasmid Construction. The plant expression vectors for overexpressing CA-rop2 (UBCA1; GZ47), CPL1 (BZ01), and CPL1-FAST (BZ02) and for inducible expression of CA-rop2 in yeast (BZ04 and BZ06) were constructed by PCR-based cloning as described in detail in SI Appendix, SI Materials and Methods.
Regular and Quantitative RT-PCR. RT-PCR analysis of the Arabidopsis CAE2 transcript and quantitative real-time PCR analysis of PME17, WAK1, and At2g47550/ invertase genes were performed using gene-specific primers (SI Appendix, Table  S1 ). For quantitative PCR analysis, gene expression values were normalized to ACT2. For quantitative PCR analysis of fission yeast Rho1, Rga1, and Pmc5 expression, primers were included in SI Appendix, Table S1 , and normalization was described in SI Appendix, SI Materials and Methods.
Western Blot. Seedlings were grounded in liquid nitrogen to extract total protein. For yeast protein experiments, cells were collected and mechanically disrupted with glass beads. Standard Western blot procedure was used, and proteins were detected using Ser2P-, Ser5P-, and Ser7P-specific antibodies and anti-Rpb1 and anti-tubulin antibodies (SI Appendix, SI Materials and Methods). Results were visualized by the chemiluminescent method (Thermo, 34096).
Protein Degradation. For in vitro degradation, protein purified from 35S:CPL1-FAST transgenic plants was mixed with an equal amount of crude extracts of WT and CA1-1, respectively, in the presence of 1 mM ATP with and without the proteasome inhibitors MG132 and lactacystin. After incubation, proteins were detected using an anti-Flag antibody. For in vivo Fcp1 protein degradation in yeast, nuclear extracts from the budding yeast transformants carrying the CA-rop2 expression vector were detected using an anti-Fcp1 antibody or an anti-Flag antibody for the 3xFlag-tagged Fcp1 strain with or without MG132 and lactacystin.
Cotyledon Cell Imaging and Quantitative Analysis. Images of cotyledon cells were collected using either agarose gel imprinting (60) or an ethanol/acetic acid treatment-based method (30) . The Shape Factor was determined using the equation (4π × area/perimeter 2 ) as described (29) . Statistical analysis was performed using one-way ANOVA.
Yeast Materials, Growth, and Transformation. The S. pombe cdc42-1625, rpb1-S2A, (S5) 3 (S5A) 11 , and (S5) 2 (S5A) 12 mutants and their corresponding WT strains were cultured in YPAD (yeast extract, peptone, adenine, and dextrose) medium or Edinburgh minimal medium (EMM). The S. cerevisiae W303-1B WT and the Fcp1-3xFlag strains were cultured in YPAD medium or SC (Synthetic Complete) minimal medium. The electroporation method was used for yeast transformation. Cell shape and Rpb1 CTD S2P and S5P levels were analyzed in the transformants or mutants.
